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que morphology and acute SM area were the predictors for late
phase SM, and late phase SM was associated with the presence
of IS-Th at 8-mo, which could be the substrate for late stent
thrombosis.
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BACKGROUND Stenting-induced edge dissections (ED) can be
assessed in detail by OCT. This study sought to investigate
the incidence, morphological characteristics, and spontaneous
healing course of optical coherence tomography (OCT) identiﬁed
EDs following drug-eluting stent (DES) implantation in a Non-ST
segment Elevation Myocardial Infarction (NSTEMI) patient-
population.
METHODS Acute vessel wall injury at the 5-mm stent adjacent
distal and proximal reference segments was assessed by post-
procedure OCT and intravascular ultrasound (IVUS) in n¼97
NSTEMI-patients (n¼97 lesions). Six months OCT follow-up was
available in 82 patients (including 35 untreated post-procedure
EDs).
RESULTS The overall incidence of post-procedure OCT-detected
ED was 38 per 97 patients (39.2%), and 47 per 182 stent edges
(25.8%). None of the EDs were angiographically visualizable, while
10 (21.3%) were visible on concomitant IVUS-analysis. Morpho-
logically, there was a signiﬁcant difference in plaque type present
at ED-edges vs. non-ED-edges when assessed with OCT; (1) lipid-
rich and calciﬁed plaques: 80.9% vs. 57.0%, (2) ﬁbrous plaque:
17.0% vs. 26.7%, and (3) normal coronary vessel: 2.1% vs. 16.3%,
p<0.01. Plaque burden, assessed by IVUS, was substantially larger
at ED-containing borders: 54.5  10.0% vs. 43.7  11.6%, p¼0.01.
Three dissections (8.6%) were incompletely healed at 6-month
OCT follow-up. None of the EDs caused cardiac events during the
6-month follow-up, however, 1 ED-patient had target lesion
revascularization with PCI and DES-implantation in extension of
the scheduled OCT-control.CONCLUSIONS OCT-detected EDs were frequent after stent implan-
tation due to NSTEMI, and the majority of these EDs healed without
leading to an adverse prognosis at 6 months.
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BACKGROUND Late stent thrombosis is an infrequent complication of
PCI, but is associated with high risk of recurrent ischemic events. OCT
can help determine the mechanism of stent thrombosis and thus
optimize management. We hypothesize that the use of OCT in stent
thrombosis will substantially change how PCI is performed.
METHODS SAFE (Study of Late Stent Failure Evaluated by OCT) is a
multicenter registry of consecutive cases of late stent thrombosis (>30
days) who underwent diagnostic OCT before intervention. In-
vestigators agreed on a treatment approach (repeat stenting or
Table 3. OCT ﬁndings of in-stent restenosis between generations of DES
1st generation (n¼54) 2nd generation (n¼32) p
TCFA 18 (33.3%) 4 (12.5%) 0.032
Lipidic neointima 50 (92.6%) 27 (87.1%) 0.404
Calciﬁc neointima 6 (11.1%) 3 (9.4%) 0.799
Thrombi 25 (46.3%) 15 (46.9%) 0.421
Rupture 23 (42.6%) 8 (25.0%) 0.100
Microvessel 30 (55.6%) 17 (53.1%) 0.827
TCFA or Rupture 30 (55.6%) 8 (25.0%) 0.006
ISR pattern 0.104
Homogenous 20 (37.0%) 12 (48%)
Heterogenous 26 (48.1%) 6 (24.0%)
Layered 8 (14.8%) 7 (28.0%)
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expansion being performed ﬁrst, while repeat stenting was reserved
for cases with signiﬁcant intrastent tissue proliferation. Both the
angiogram and the pre-intervention OCT were analyzed separately by
the core lab team. For each case, the core lab would assign a virtual
treatment approach based on the angiogram alone or based on the
OCT alone.
RESULTS 70 cases of late stent thrombosis were analyzed. Based
on OCT, intrastent thrombus was identiﬁed in all the cases.
Excessive tissue proliferation was noted in 27 patients, uncovered /
malapposed struts in 27 patients, both ﬁndings in 14 patients, and
no clear culprit in 2 patients. By angiography, excessive tissue
proliferation was noted in 37 patients, uncovered/malapposed
struts in 19 patients, and no clear culprit in 14 patients. There was
poor agreement between OCT and angiography (kappa 0.11,
p¼0.11). Based on the proposed algorithm, the virtual treatment
strategy was changed by OCT relative to angiography guidance in
32.8% of the cases, with repeat stenting advocated for only 51% of
the cases.
CONCLUSIONS OCT can effectively identify multiple intra-stent pa-
thologies in late stent thrombosis. Information obtained from OCT can
substantially change how PCI is performed when a predeﬁned treat-
ment algorithm is followed.
CATEGORIES IMAGING: Intravascular
KEYWORDS OCT, Stent thrombosis, late
TCT-47
Comparative Optical Coherent Tomographic analysis of in-stent
neoatherosclerosis between 1st and 2nd generation drug-eluting stent
Mineok Chang,1 Jae-Hyung Roh,1 Pil Hyung Lee,1 Byeong Joo Bae,1
Hee-Soon Park,2 Se Hun Kang,1 Cheol Hyun Lee,1 Min Soo Cho,1
Jae Seok Bae,1 Yu Na Kim,1 Sung-Han Yoon,1 Jung-Min Ahn,1
Duk-Woo Park,3 Soo-Jin Kang,1 Seung-Whan Lee,1 Young-Hak Kim,1
Cheol Whan Lee,1 Seong-Wook Park,1 Seung-Jung Park1
1Asan Medical Center, Seoul, Korea, Republic of; 2Asan medical center,
Seoul, Korea, Republic of; 3Asan Medical Center, Seoul, Korea, Seoul,
Korea, Republic of
BACKGROUND Although in-stent neoatherosclerosis contributes to
late failure of bare metal and ﬁrst generation drug eluting stent (DES),
there is lack of data on new, 2nd generation DES. The aim of this study
was to compare the characteristics of in-stent neoatherosclerosis of
2nd generation DES and 1st generation DES using optical coherence
tomography (OCT).
METHODS Pre-procedural OCT and grayscale intravascular ultra-
sound were analyzed in 86 patients (58 stable angina, 28 acute coro-
nary syndrome) who underwent clinically-driven target lesion
revascularization (TLR) within the 4 years after DES placement. 1st
generation DES group was composed of 16 sirolimus-eluting stents
and 35 paclitaxel-eluting stents; and 2nd generation DES was
composed of 21 everolimus-eluting stents, 9 zotarolimus-eluting
stents, and 2 novolimus-eluting stents.
RESULTS The median duration for target lesion failure were 11.2
months (IQR 5.7-23.6 months) in 1st generation DES and 8.9 months
(IQR 6.1-15.9 months) in 2nd generation DES (p¼0.222). In both gen-
erations, focal stenosis was the predominant type of angiographic
restenosis. Overall, 1st generation DES had more frequent OCT-
deﬁned in-stent thin-cap ﬁbroatheroma (TCFA)–containing neo-
intimal lesions than 2nd generation DES (33.3% vs 12.5%, p¼0.032)
and the signiﬁcance was mainly developed after 12 months of DES
implantation (TLR <12 months after implantation, 15.0% vs 18.2%,
p¼0.818, DES 12 months after implantation, 44.1% vs 9.5%,
p¼0.007). Otherwise there were no differences in other of unstable
neointimal morphology such as the frequency of rupture (42.6% vs.
25.0%, p¼0.100), thrombi (46.3% vs. 46.9%, p¼0.421) or microvessel
(55.6% vs. 53.1%, p¼0.827).
CONCLUSIONS The OCT morphological characteristics of in-stent
neoatherosclerosis between generations of DES were similar. But 2nd
generation DES demonstrated lesser OCT-detected TCFA than 1st
generation DES, especially after 12 months of implantation.CATEGORIES IMAGING: Intravascular
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